DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series.

Acute generalized exanthematous pustulosis Cutaneous adverse drug reaction Drug reaction with eosinophilia and systemic symptoms Iodinated contrast media Skin tests

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
08 2021
Historique:
received: 04 01 2021
revised: 23 02 2021
accepted: 28 02 2021
pubmed: 25 3 2021
medline: 28 10 2021
entrez: 24 3 2021
Statut: ppublish

Résumé

Drug reactions with eosinophilia and systemic symptoms (DRESSs) and acute generalized exanthematous pustulosis (AGEP) are potentially severe cutaneous adverse drug reactions. To describe the clinical findings and sensitization profiles of DRESS and AGEP patients who had been administered iodinated contrast media (ICM). All adult patients in the dermatologist's French Investigators for Skin Adverse Reactions to Drugs (FISARD) network diagnosed with a DRESS or AGEP highly suspected to have been caused by an ICM were included retrospectively. Thirteen DRESS patients and 19 AGEP patients who had been administered ICM were included, and the median delay in DRESS and AGEP occurrence after ICM administration was short, 4 and 1 days, respectively. Five AGEP patients had systemic involvement. A high cosensitization rate (46%) was observed among the DRESS patients, mainly with beta-lactam antibiotics. Overall, 77% of our patients were sensitized to several ICM. Patch tests identified the suspected ICM for 21 cases (72%). The retrospective nature, the limited number of subjects, the absence of a control group of healthy individuals, and the lack of detailed information on previous exposure to sensitizing drugs are limitations of this study. We report a large series of DRESSs and AGEPs related to ICM administration. Skin tests appear useful for diagnosis and potentially to identify alternative ICM.

Sections du résumé

BACKGROUND
Drug reactions with eosinophilia and systemic symptoms (DRESSs) and acute generalized exanthematous pustulosis (AGEP) are potentially severe cutaneous adverse drug reactions.
OBJECTIVE
To describe the clinical findings and sensitization profiles of DRESS and AGEP patients who had been administered iodinated contrast media (ICM).
METHODS
All adult patients in the dermatologist's French Investigators for Skin Adverse Reactions to Drugs (FISARD) network diagnosed with a DRESS or AGEP highly suspected to have been caused by an ICM were included retrospectively.
RESULTS
Thirteen DRESS patients and 19 AGEP patients who had been administered ICM were included, and the median delay in DRESS and AGEP occurrence after ICM administration was short, 4 and 1 days, respectively. Five AGEP patients had systemic involvement. A high cosensitization rate (46%) was observed among the DRESS patients, mainly with beta-lactam antibiotics. Overall, 77% of our patients were sensitized to several ICM. Patch tests identified the suspected ICM for 21 cases (72%). The retrospective nature, the limited number of subjects, the absence of a control group of healthy individuals, and the lack of detailed information on previous exposure to sensitizing drugs are limitations of this study.
CONCLUSIONS
We report a large series of DRESSs and AGEPs related to ICM administration. Skin tests appear useful for diagnosis and potentially to identify alternative ICM.

Identifiants

pubmed: 33757916
pii: S2213-2198(21)00318-4
doi: 10.1016/j.jaip.2021.02.060
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3041-3050

Informations de copyright

Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Angèle Soria (A)

Sorbonne Universités, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris, France. Electronic address: angele.soria@aphp.fr.

Emmanuelle Amsler (E)

Sorbonne Universités, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France.

Claire Bernier (C)

Service de Dermatologie, Hôpital Hôtel Dieu, CHU Nantes, France.

Brigitte Milpied (B)

Service de Dermatologie, Hôpital Saint André, Bordeaux, France.

Florence Tétart (F)

Clinique dermatologique CHU de Rouen et Centre Erik Satie, Allergologie CHU Rouen, France.

Cécile Morice (C)

Service de Dermatologie, Caen, France.

Frédéric Dezoteux (F)

Service de Dermatologie, Hôpital Claude Huriez, CHU Lille, France.

Marie-Christine Ferrier-Le Bouedec (MC)

Service de Dermatologie, CHU Estaing, Clermont-Ferrand, France.

Annick Barbaud (A)

Sorbonne Universités, Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France.

Delphine Staumont-Sallé (D)

Service de Dermatologie, Hôpital Claude Huriez, CHU Lille, France.

Haudrey Assier (H)

Service de Dermatologie, Hôpital Henri Mondor, APHP, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH